Radcliffe Capital Management’s ARYA Sciences Acquisition Corp V Class A Ordinary Shares ARYE Stock Holding History

Radcliffe Capital Management’s Portfolio ARYE Stock Details ARYE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-243,144	Closed	-$2.52M	–	575
2023 Q2	$2.52M	Buy	243,144 +34,426	+16%	+$354K	0.21%	157
2023 Q1	$2.14M	Buy	208,718 +3,465	+2%	+$35.1K	0.13%	211
2022 Q4	$2.07M	Buy	205,253 +170	+0.1%	+$1.69K	0.07%	449
2022 Q3	$2.02M	Buy	205,083 +97	+0%	+$948	0.05%	637
2022 Q2	$1.99M	Buy	204,986 +3,612	+2%	+$35.1K	0.05%	680
2022 Q1	$1.96M	Buy	201,374 +1,374	+0.7%	+$13.3K	0.04%	685
2021 Q4	$1.94M	Hold	200,000	–	–	0.05%	600
2021 Q3	$1.98M	Buy	+200,000	New	+$1.99M	0.06%	470

Radcliffe Capital Management's ARYE Position: Q3 2023 in Review

Radcliffe Capital Management sold out of ARYA Sciences Acquisition Corp V Class A Ordinary Shares (ARYE) in Q3 2023, closing a stake of 243,144 shares — an estimated $2.52M sold.

Radcliffe Capital Management first reported a position in ARYE in Q3 2021 and held it in 8 quarters. The position peaked at $2.52M in Q2 2023. 0 funds tracked by Wall St. Rank hold ARYE as of Q3 2023.

Radcliffe Capital Management reported no remaining ARYA Sciences Acquisition Corp V Class A Ordinary Shares position as of Q3 2023 after selling out during the quarter.
Radcliffe Capital Management sold 243,144 ARYA Sciences Acquisition Corp V Class A Ordinary Shares shares in Q3 2023, an estimated $2.52M.
Radcliffe Capital Management first reported a position in ARYA Sciences Acquisition Corp V Class A Ordinary Shares in Q3 2021 and held it in 8 quarters.
Radcliffe Capital Management's ARYA Sciences Acquisition Corp V Class A Ordinary Shares position peaked at $2.52M in Q2 2023.
0 funds tracked by Wall St. Rank held ARYA Sciences Acquisition Corp V Class A Ordinary Shares as of Q3 2023.

Based on Radcliffe Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.